CID 118752983

Sipoglitazar metabolite m-i

Structural Information

Molecular Formula
C23H21N3O4S
SMILES
C1=CC=C(C=C1)C2=NC(=CS2)COC3=CC=C(C=C3)CN4C=C(C(=O)N4)CCC(=O)O
InChI
InChI=1S/C23H21N3O4S/c27-21(28)11-8-18-13-26(25-22(18)29)12-16-6-9-20(10-7-16)30-14-19-15-31-23(24-19)17-4-2-1-3-5-17/h1-7,9-10,13,15H,8,11-12,14H2,(H,25,29)(H,27,28)
InChIKey
FLJUMKJOWRMKTG-UHFFFAOYSA-N
Compound name
3-[5-oxo-2-[[4-[(2-phenyl-1,3-thiazol-4-yl)methoxy]phenyl]methyl]-1H-pyrazol-4-yl]propanoic acid
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

1
References

0
Patents

435.12527 Da
Monoisotopic Mass

3.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 436.13255 201.1
[M+Na]+ 458.11449 209.9
[M-H]- 434.11799 209.5
[M+NH4]+ 453.15909 209.2
[M+K]+ 474.08843 202.7
[M+H-H2O]+ 418.12253 191.9
[M+HCOO]- 480.12347 216.7
[M+CH3COO]- 494.13912 210.1
[M+Na-2H]- 456.09994 197.7
[M]+ 435.12472 206.7
[M]- 435.12582 206.7
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.